Bruker BRKR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $197.5M-5.0% | $267M-2.0% | $208.7M-10.4% | $195.3M-10.2% | $207.8M+13.7% | |
| Bsi Calid | $316.3M+12.9% | $331.6M+3.4% | $312.7M+11.9% | $285.8M+7.6% | $280.1M+22.9% | |
| Bsi Nano | $246M-4.1% | $309.1M-2.9% | $266.5M-7.2% | $252.1M-0.2% | $256.6M+6.7% | |
| Energy And Supercon Technologies | $66.8M+12.6% | $71.5M-0.8% | $73.8M+7.4% | $66.3M-4.1% | $59.3M-18.9% | |
| Revenue by Product | ||||||
| Product And Service Other | $177M+12.0% | $179.9M+5.2% | $169.4M+9.2% | $162.7M+11.2% | $158.1M+17.3% | |
| Product | $646.4M+0.5% | $797.3M-1.4% | $691.1M-2.6% | $634.7M-3.0% | $643.3M+9.6% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $134.7M+2.5% | $163.1M-0.7% | $130.7M-7.4% | $127.4M+20.0% | $131.4M+22.8% | |
| CN | $74M-26.9% | $138.1M+21.4% | $121.8M+0.4% | $114.7M-4.7% | $101.2M-12.5% | |
| DE | $62.7M+2.6% | $105.5M+22.5% | $71.3M-4.0% | $59.1M-29.2% | $61.1M-8.5% | |
| Europe Excluding Germany | $258.9M+15.5% | $271.5M-5.4% | $241.2M+11.9% | $213.4M+11.0% | $224.1M+25.8% | |
| Other Country | $71.2M+7.6% | $74M+9.6% | $69.5M-4.9% | $59.9M+9.7% | $66.2M+11.6% | |
| US | $221.9M+2.1% | $225M-13.8% | $226M-5.4% | $222.9M-8.5% | $217.4M+11.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
